Apixaban and Right ventricular hypertrophy - a phase IV clinical study of FDA data
Summary:
Right ventricular hypertrophy is reported as a side effect among people who take Apixaban (apixaban), especially for people who are male, 60+ old, also take Pantoprazole, and have Asthma.
The phase IV clinical study analyzes which people have Right ventricular hypertrophy when taking Apixaban. It is created by eHealthMe based on reports of 60,044 people who have side effects when taking Apixaban from the FDA, and is updated regularly.
What is Apixaban?
Apixaban has active ingredients of apixaban. It is often used in blood clots. eHealthMe is studying from 60,351 Apixaban users. Check the latest studies of Apixaban.
What is Right ventricular hypertrophy?
Right ventricular hypertrophy (right ventricular enlargement) is found to be associated with 232 drugs and 308 conditions by eHealthMe. Check the latest studies of Right ventricular hypertrophy.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
60,044 people reported to have side effects when taking Apixaban.
Among them, 140 people (0.23%) have Right ventricular hypertrophy.
Among these 140 people:
What is the gender of people who have Right ventricular hypertrophy when taking Apixaban? *
What is the age of people who have Right ventricular hypertrophy when taking Apixaban? *
What are other drugs people take besides Apixaban? *
What are other side effects people have besides Right ventricular hypertrophy? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Apixaban and have Right ventricular hypertrophy?
- Check whether Right ventricular hypertrophy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Apixaban:
- Apixaban (60,351 reports)
Right ventricular hypertrophy treatments and more:
- Right ventricular hypertrophy (1,612 reports)
How severe was Right ventricular hypertrophy and when was it recovered:
Expand to all the drugs that have ingredients of apixaban:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Apixaban:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Right ventricular hypertrophy:
- Right ventricular hypertrophy (232 drugs)
Browse all the conditions that are associated with Right ventricular hypertrophy:
- Right ventricular hypertrophy (308 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on apixaban (the active ingredients of Apixaban) and Apixaban (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Oxycodone and Yellow Skin And Eyes for Men aged 50-59 - 2 seconds ago
- Oxycodone and Skin - Yellow for Men aged 50-59 - 3 seconds ago
- Oxycodone and Jaundice for Men aged 50-59 - 3 seconds ago
- Oxycodone and Icterus for Men aged 50-59 - 3 seconds ago
- Oxycodone and Eyes - Yellow for Men aged 50-59 - 3 seconds ago
- Oxycodone and Jaundice - Yellow Skin for Men aged 50-59 - 4 seconds ago
- Could Losartan cause Bradykinesia? - 7 seconds ago
- Could Sertraline cause Increased Upper Airway Secretion? - 9 seconds ago
- Drug interactions of Torsemide and Zoledronic Acid - 17 seconds ago
- Drug interactions of Sildenafil Citrate and Letairis - 20 seconds ago